Valneva Q4 Earnings Call Highlights [Yahoo! Finance]
Valneva SE - American Depositary Shares (VALN)
Company Research
Source: Yahoo! Finance
Valneva (NASDAQ:VALN) executives highlighted steady full-year 2025 revenue, tighter cash discipline, and multiple clinical and commercial catalysts during the company's results and business update call. Management reiterated that upcoming pivotal phase 3 data for its Lyme disease vaccine candidate, partnered with Pfizer, remains the most significant near-term value driver, while the company continues to invest in its proprietary travel vaccine portfolio and selected pipeline programs. 2025 financial performance and cash position Chief Executive Officer Thomas Lingelbach said total revenues exceeded EUR 170 million in 2025, slightly above 2024 levels, including nearly EUR 160 million in product sales. He added that Valneva ended the year with a cash position of nearly EUR 110 million , improved financial flexibility through a successful debt refinancing, and achieved a more than 20% reduction in operating cash burn driven by disciplined cash management. ? Data Storage to Data In
Show less
Read more
Impact Snapshot
Event Time:
VALN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VALN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VALN alerts
High impacting Valneva SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
VALN
News
- Valneva SE (INRLF) Full Year 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... [Yahoo! Finance]Yahoo! Finance
- Valneva SE (VALN) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Valneva inks licensing deal with Elaris for vaccine technology [Seeking Alpha]Seeking Alpha
- Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program [Yahoo! Finance]Yahoo! Finance
- Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine ProgramPR Newswire
VALN
Sec Filings
- 3/18/26 - Form 6-K
- 3/17/26 - Form 20-F
- 3/10/26 - Form SCHEDULE
- VALN's page on the SEC website